The present invention relates to novel compounds that inhibit LRRK2 kinase activity, processes for their preparation, to compositions containing them and to their use in the treatment of or prevention of diseases characterized by LRRK2 kinase activity, for example Parkinson's disease, Alzheimer's disease and amyotrophic lateral sclerosis (ALS).
申请公布号
EP3099695(A1)
申请公布日期
2016.12.07
申请号
EP20150743797
申请日期
2015.01.28
申请人
GlaxoSmithKline Intellectual Property Development Limited
发明人
DING, Xiao;LIU, Qian;SANG, Yingxia;STASI, Luigi Piero;WAN, Zehong;ZHAO, Baowei;EDGE, Colin Michael